Tissue Factor (TF): A Master Regulator of Coagulation, Inflammation, and Tumor Progression
Tissue Factor (TF): A Master Regulator of Coagulation, Inflammation, and Tumor Progression
Published by ANT BIO PTE. LTD.
1. Concept Overview
Tissue Factor (TF, encoded by the F3 gene) is a 47 kDa transmembrane glycoprotein that acts as the primary initiator of the coagulation cascade and a multifunctional signaling hub in health and disease. Beyond its canonical role in hemostasis, TF governs inflammatory responses, immune cell function, angiogenesis, and malignant progression, positioning it as a high-priority target for translational research.
2. Research Frontiers
Recent advances have redefined TF beyond a clotting factor:
- Structural biology reveals dynamic conformational switching between encrypted and decrypted functional states, governing procoagulant activity.
- alternatively spliced human TF (asHTF) acts as a soluble isoform regulating systemic thrombotic risk.
- TF signaling via protease‑activated receptors (PAR2) links coagulation to inflammation, immunity, and cancer metastasis.
- Clinical development targets TF for anticoagulation, anti‑inflammation, and cancer therapy, including antibody–drug conjugates (ADCs) and bispecific immune engagers.
3. Research Significance
TF is indispensable for physiological hemostasis; dysregulation drives life‑threatening disorders:
- Vascular diseases: atherosclerotic plaque rupture, myocardial infarction, and stroke.
- Thromboinflammatory conditions: sepsis, acute respiratory distress, and COVID‑19‑associated coagulopathy.
- Malignancy: tumor growth, invasion, metastasis, and cancer‑associated thrombosis.
- Autoimmunity and chronic inflammation: rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Understanding TF regulation and signaling enables precision diagnostics, prognostic stratification, and novel therapeutic design across cardiovascular, oncological, and immunological disciplines.
4. Molecular Mechanisms and Research Applications
4.1 Structure and Expression Control
TF comprises an extracellular ligand‑binding region, a transmembrane segment, and a short cytoplasmic tail. Key residues Lys165/Glu166 stabilize binding to coagulation factor VII/VIIa. Under homeostasis, TF is restricted to extravascular tissues, forming a “blood–tissue barrier.” Inflammatory cytokines, hypoxia, and oxidative stress robustly induce TF in endothelial cells and monocytes via transcriptional and epigenetic mechanisms.
4.2 Coagulation Pathway Initiation
The TF–FVIIa complex triggers the extrinsic coagulation pathway, activating FX and FIX to generate thrombin and fibrin clots. This process is tightly modulated by Tissue Factor Pathway Inhibitor (TFPI), antithrombin III (ATIII), and the protein C system. TF encryption/decryption represents a rapid, reversible regulatory layer with major therapeutic implications.
4.3 Inflammation, Immunity, and Cancer
TF–FVIIa–PAR2 signaling promotes proinflammatory cytokine secretion and immune cell recruitment. In the tumor microenvironment, TF supports survival, migration, angiogenesis, and immune suppression, correlating with poor prognosis in pancreatic cancer, glioblastoma, and triple‑negative breast cancer. TF‑positive circulating tumor microemboli are emerging as actionable biomarkers and therapeutic targets.
4.4 Experimental Approaches Enabled by ANT BIO PTE. LTD. Reagents
Robust TF research relies on high‑performance tools:
- Western Blot (WB): detect full‑length and cleaved TF isoforms.
- Immunohistochemistry (IHC‑P): localize TF in formalin‑fixed, paraffin‑embedded tissues.
- Immunocytochemistry (ICC/IF): visualize subcellular TF distribution in cultured cells.
- ELISA Kits: quantify soluble TF or asHTF in plasma, serum, or cell supernatants.
- Recombinant proteins: support structural, binding, and functional assays.
5. Our Mission at ANT BIO PTE. LTD.
ANT BIO PTE. LTD. empowers life science breakthroughs by delivering validated, high‑quality reagents for coagulation, inflammation, and oncology research. Our portfolio supports every stage of TF investigation—from molecular mechanism to clinical translation—with rigorously validated antibodies, recombinant proteins, and detection kits.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high‑quality, reliable reagents and comprehensive solutions. Our specialized sub‑brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer‑centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Would you like me to convert this article into clean HTML format ready for direct website upload?
